Clinical Characteristics Associated with Metastatic Nsclc Harboring Alk Rearrangements in Chinese Patients.
Guangming Tian,Xinliang Zhao,Jun Nie,Ling Dai,Weiheng Hu,Jie Zhang,Xiaoling Chen,Jindi Han,Xiangjuan Ma,Di Wu,Sen Han,Yang Wang,Jieran Long,Jian Fang
DOI: https://doi.org/10.1200/jco.2016.34.15_suppl.e20628
IF: 45.3
2016-01-01
Journal of Clinical Oncology
Abstract:e20628 Background: In NSCLC patients harboring specific genetic changes, such as ALK rearrangement and EGFR mutations, targeted therapies have exhibited considerable therapeutic potential. As the genetic susceptibilities of tumors vary between populations, we conducted a retrospective study to investigate the populational difference between EGFR, ALK positive groups. Methods: Data were collected on patients with NSCLC who were admitted Peking University Cancer Hospital, during Nov 2011 - Dec 2015. The clinical data collected for each patient included age, gender, smoking history, histological tumor type, disease stage at the time of treatment, and results of detecting the ALK fusion gene and EGFR mutations. Results: 595 patients admitted to our institution with a pathological diagnosis of NSCLC, among which 357 were at the stage of IIIb - IV and tested for ALK translocation and EGFR mutation. A total of 37 patients (10.4%) were found to be ALK fusion gene-positive; 19 of the 223 male patients were positive (8.5%). Pearson Chi-square analysis of the gender data showed no statistical significance (χ2 = 2.174; P = 0.140). The median age of the ALK-positive patients was 50 (range, 21-70 years), and it was 58 for ALK negative (range from 15 to 81). Analyzed by the ANOVA test, this difference in age of occurrence was statistically significant (F = 23.81; P < 0.001). 25 of the ALK positive patients (67.6%) were non/light smokers. In ALK negative patients, the number of smokers and non/light smokers were 172 and 148. The difference of postive rate between two smoking groups was significant (χ2 = 5.21; P = 0.014) . EGFR muation were found in 118 patients (33.1%). Among the mutation group, median age of the patients was 57, 53 were male (44.9%), and 36 were smokers (30.5%). In the patients with ALK or EGFR muations, the distribution of age were different (F = 15.47, P < 0.001), and the distributions of smoking condition (χ2= 0, P = 0.823), gander (χ2= 0.25, P = 0.493) were not different. Conclusions: By perfoming the current study, we identified that the ALK translocation were more likely to be found in young and non/light smoking NSCLC patients in China, and the patients harboring ALK translocation were younger than those with EGFR mutations.